SIBUR Develops New Polymer Grades for Medical and Packaging Applications
MOSCOW, RUSSIA - Media OutReach Newswire – 30 May 2025 - SIBUR, Russia's largest producer of polymers and rubbers, has developed new product grades tailored for the medical industry and e-commerce packaging.A new grade of polypropylene resistant to radiation exposure can be used in the production of test tubes, containers, and other medical items that undergo radiation sterilisation. These products retain their original strength, transparency, and colour after sterilisation.To confirm its radiation resistance, the material was subjected to a dose 40% higher than standard. The results demonstrated the material's high reliability: it maintained its properties and met customer requirements even under increased exposure. This grade of polypropylene has excellent export potential.SIBUR Polylab, the company's R&D centre, has also developed a new material formula for e-commerce courier bags that combines low- and high-density polyethylene. This innovation reduced the bags' weight by up to 30% without compromising their strength.The courier bags feature tamper-evident seals, protect against moisture and contaminants, and allow for direct printing of unique QR codes on the surface without labels. Compared with cardboard boxes, this type of packaging lowers delivery costs due to its smaller size and lighter weight.In 2024, SIBUR enhanced its corporate structure by transitioning to industry-specific divisions. Each division focuses on the development and implementation of polymer solutions for specific sectors, including healthcare, packaging, construction, automotive, and others. This approach fosters both sales growth and innovation.The Russian market remains SIBUR's top priority, though the company also exports products to China, Vietnam, and other Asian countries. In 2026, SIBUR plans to launch the Amur Gas Chemical Complex, with a production capacity of 2.7 million tonnes of polyethylene and polypropylene per year, which will help expand exports to Southeast Asia.Hashtag: #SIBUR
The issuer is solely responsible for the content of this announcement.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Free Malaysia Today
10 hours ago
- Free Malaysia Today
Mercedes sees itself as ‘sounding board' in tariff talks, says CEO
Mercedes-Benz CEO Ola Kaellenius said negotiations take place at the EU level because trade policy falls within the EU's remit. (EPA Images pic) BERLIN : Mercedes-Benz views itself as a 'sounding board' that contributes ideas in tariff negotiations between the EU and the US, CEO Ola Kaellenius told the Frankfurter Allgemeine Zeitung newspaper today. 'As a company, we hold talks with political decision-makers – in the EU as well as in China and the US,' said Kaellenius. 'However, negotiations take place at EU level because trade policy falls within the EU's remit. 'We are available as a sounding board, contributing ideas and presenting scenarios showing how certain decisions would affect us,' he added. Mercedes-Benz, as well as BMW and Volkswagen, are in talks with Washington over a possible import tariff deal, sources told Reuters late last month. 'Under one proposal on the table, German carmakers would get credits for cars they export from the US, which could then be deducted from tariffs,' one of the sources said. Kaellenius' interview was published hours before Germany's new chancellor, Friedrich Merz, will hold his first face-to-face talks with US President Donald Trump as Europe seeks to stave off looming US tariffs.
Malay Mail
12 hours ago
- Malay Mail
Want to have a baby? UK warns against ‘skinny jabs' like Ozempic, Wegovy as animal tests show potential harm to newborns
LONDON, June 5 — The UK's medicine regulator warned Thursday against taking 'skinny jabs' to fight weight loss if trying to get pregnant or while breastfeeding because of their unknown effects on babies. The Medicines and Healthcare products Regulatory Agency (MHRA) said popular jabs like Ozempic and Wegovy 'must not be taken during pregnancy, while trying to get pregnant, or during breastfeeding'. It urged women to use 'effective contraception while taking these medicines and, in some cases, for up to two months between stopping the medicine and trying to get pregnant'. 'Anyone who gets pregnant while using them should speak to their healthcare professional and stop the medicine as soon as possible... because there is not enough safety data to know whether taking the medicine could cause harm to the baby,' it added. Rebecca Reynolds, a professor of metabolic medicine at the University of Edinburgh, said there was 'hardly any available data from human studies' to know if the weight loss drugs were safe in pregnancy. 'The data from animal studies suggests the potential for harm with low birthweight and skeletal abnormalities, though more evidence is needed to assess if there are risks of taking these drugs in humans,' she added. The MHRA also warned about the impact of another weight-loss and diabetes injection, Mounjaro, on the effectiveness of oral contraception for people who are overweight. 'Therefore, those taking Mounjaro who are overweight and are using an oral form of contraception are advised to also use a non-oral form of contraception,' it said. Ying Cheong, a consultant in reproductive medicine at the University of Southampton, called the MHRA's advice 'both timely and necessary'. 'Gastrointestinal side-effects such as vomiting and diarrhoea can impair oral contraceptive absorption, increasing the risk of unintended pregnancy,' he said. — AFP
Free Malaysia Today
14 hours ago
- Free Malaysia Today
Clean energy investment rising despite economic uncertainty, says IEA
The International Energy Agency said the shift in US policies is expected to impact investment in renewable energy. (Freepik pic) PARIS : Investment in clean energy technologies is set to strike a record this year despite global economic uncertainty, double the spending on fossil fuels that will dip for the first time since 2020, the International Energy Agency (IEA) said today. While the Trump administration has been hostile to renewable energy sources and trumpets boosting oil production, the IEA said security concerns, as well as rising demand for electricity, including from artificial intelligence (AI) and data centres, are driving investment in clean energy sources. 'Amid the geopolitical and economic uncertainties that are clouding the outlook for the energy world, we see energy security coming through as a key driver of the growth in global investment this year to a record US$3.3 trillion as countries and companies seek to insulate themselves from a wide range of risks,' executive director Fatih Birol said as the IEA published its latest annual World Energy Investment report. It expects investment in clean technologies, including nuclear and electricity distribution grids, to hit a record US$2.2 trillion this year. Meanwhile, investment in oil, natural gas and coal is set to dip to US$1.1 billion, as companies react to falling prices and lower demand expectations. Most of drop is due to investment in US oil production, while investment in liquefied natural gas (LNG) projects there and elsewhere is expected to lead to the largest-ever capacity growth in 2026-2028. Since returning to the White House, Trump has slapped a 10% tariff on most trading partners, alongside higher rates on dozens of economies, including China and the EU, that have since been reduced or put on pause until early July while negotiations are held. Earlier this week the OECD slashed its annual global growth forecast, warning that Trump's tariffs blitz would stifle the world economy. However, energy investments haven't suffered yet. 'The fast-evolving economic and trade picture means that some investors are adopting a wait-and-see approach to new energy project approvals, but in most areas we have yet to see significant implications for existing projects,' Birol said. US renewables to 'level off' However, IEA said the shift in US policies would impact investment there in renewables. 'Spending on renewables and low-emissions fuels in the US almost doubled over the last 10 years but is now set to level off as supportive policies are scaled back,' it said. The report found the rapid rise in electricity demand – for industry, cooling, electric mobility, data centres and AI – was also shaping investment trends. The sector is expected attract US$1.5 trillion in investments this year, 50% more than fossil fuels. The IEA also noted that nuclear energy has been making a comeback as electricity demand from data centres risks doubling in the next five years. While renewables are expected to meet most of that additional demand, the steady supply that nuclear plants offer have prompted a number of tech companies to enter into supply agreements. However, the Paris-based IEA, which advises industrial nations on energy policy, warned that spending on electricity grids was not keeping up with investment into generation. In addition to lengthy permitting procedures, grid expansion was also being held back by tight supply of transformers and cable, it found. Despite the rising levels of investment in renewable energy production, the IEA said it must double to achieve the goal set at the 2024 UN climate conference: a tripling of the installed renewable capacity by 2030. The urgent demand for power means new plants using dirty fuels such as coal are still being built, with a 4% increase in investment expected this year. 'In the face of rapid electricity demand growth and concerns linked to security of supply, such as various geopolitical risks as well as uncertainties over hydropower output, China and India are approving increasing amounts of new coal-fired power,' said the IEA report.
